Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using rtog study 7916

International Journal of Radiation Oncology, Biology, Physics

Volumn 16, Issue 3, 1989, Pages 669-673

  Diener West, Marie ^a   Dobbins, Thomas W ^b   Phillips, Theodore L ^c   Nelson, Diana F ^d  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Highland Hospital Rochester   (United States)

Author keywords

Brain metastases; Prognostic subgroups; Radiation therapy; RTOG

Indexed keywords

MISONIDAZOLE;

ADULT; AGED; BRAIN METASTASIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PRIORITY JOURNAL; RADIOSENSITIZATION;

BRAIN NEOPLASMS; HUMAN; MIDDLE AGE; MULTICENTER STUDIES; PROGNOSIS; REGRESSION ANALYSIS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024517833     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(89)90483-5     Document Type: Article

References (11)

1. The palliation of brain metastases: Final results of the first two studies by the Radiation Therapy Oncology Group
2. 2 tests
3. Regression models and life tables
4. Equivalence of radiation schedules for the palliative treatment of brain metastases in patients with favorable prognosis
5. Nonparametric Estimation from Incomplete Observations
6. The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinoma
7. The palliation of brain metastases in a favorable patient population: A randomized clinical trial by the Radiation Therapy Oncology Group
8. Evaluation of survival data and two new rank order statistics arising in its consideration.
9. Hypofractionated radiotherapy with or without misonidazole for the treatment of brain metastases
10. Biologic basis for altered fractionation schemes